Distributed Access to Critical Biotherapeutics for Warfighters

Abstract

The goal of the Distributed Access to Critical Biotherapeutics for Warfighters program is to ensure DoD access to critical medical countermeasures (MCMs) by establishing the foundational technologies needed for fully distributable, on-demand manufacturing of protein-based MCMs and critical reagents. To achieve this, investments will be made in technologies that enable immediate, high-yield synthesis of bioactive protein MCMs. This technology will allow the DoD to rapidly secure access to therapeutic proteins and to enzymes needed for nucleic-acid based MCM synthesis without reliance on complex supply chains or slow development cycles.

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2023
Source ID
82dbde9ba6dada07bb00a03036cfa66b

Tags

Fields of Study

  • Engineering

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Defense Technology Research and Development.
  • Molecular and Cellular Biochemistry

Technology Areas

  • Biotechnology

Related Documents